Abera Bioscience AB (NGM:ABERA)

Abera Bioscience AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	107	69	75	62	173	-
Market Cap Growth	-7.22%	-7.22%	20.46%	-64.21%	-	-
Enterprise Value	101	66	73	49	159	-
Last Close Price	6.95	4.51	5.16	4.80	16.55	-
PS Ratio	7.19	4.66	29.56	34.66	146.97	-
PB Ratio	12.33	8.00	13.19	3.69	5.94	-
P/TBV Ratio	12.33	8.00	13.19	3.69	5.94	-
EV/Sales Ratio	6.78	4.45	28.82	27.67	135.29	-
Asset Turnover	1.29	1.29	0.18	0.07	0.07	0.19
Quick Ratio	1.36	1.36	1.10	5.80	5.51	0.43
Current Ratio	2.15	2.15	2.01	6.33	5.60	0.43
Return on Equity (ROE)	-15.37%	-15.37%	-149.01%	-84.39%	-61.97%	-161.90%
Return on Assets (ROA)	-6.10%	-6.10%	-73.12%	-47.73%	-33.40%	-58.94%
Return on Capital (ROIC)	-9.78%	-9.78%	-94.27%	-52.95%	-38.77%	-102.87%
Earnings Yield	-103.09%	-1.59%	-22.40%	-31.28%	-5.29%	-
FCF Yield	-124.56%	-1.92%	-23.73%	-31.78%	-5.59%	-
Buyback Yield / Dilution	-1844.20%	-18.44%	-13.64%	-14.64%	-45.39%	-200.47%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.